Emerging Therapies for Acute Myelogenus Leukemia Patients Targeting Apoptosis and Mitochondrial Metabolism

Acute Myelogenous Leukemia (AML) is a malignant disease of the hematopoietic cells, characterized by impaired differentiation and uncontrolled clonal expansion of myeloid progenitors/precursors, resulting in bone marrow failure and impaired normal hematopoiesis. AML comprises a heterogeneous group o...

Descripción completa

Detalles Bibliográficos
Autores principales: Castelli, Germana, Pelosi, Elvira, Testa, Ugo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6406361/
https://www.ncbi.nlm.nih.gov/pubmed/30813354
http://dx.doi.org/10.3390/cancers11020260

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6406361/
https://www.ncbi.nlm.nih.gov/pubmed/30813354
http://dx.doi.org/10.3390/cancers11020260

Ejemplares similares